Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

NCT00189306 ·Status: COMPLETED ·Phase: PHASE3

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma

NCT00803907 ·Status: UNKNOWN ·Phase: PHASE4

Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery

NCT01212562 ·Status: COMPLETED

Basal Cell Carcinoma Chemoprevention Trial

NCT05212246 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

NCT00175643 ·Status: COMPLETED ·Phase: PHASE3

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

NCT06840470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma

NCT02301494 ·Status: WITHDRAWN ·Phase: NA

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

NCT00774787 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma

NCT01808950 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Topical Imiquimod Treatment of Oral Dysplasia

NCT07210775 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

NCT03233412 ·Status: COMPLETED ·Phase: PHASE2

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

NCT00504023 ·Status: COMPLETED ·Phase: NA

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

NCT00638651 ·Status: COMPLETED ·Phase: PHASE1

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

NCT00761371 ·Status: COMPLETED ·Phase: PHASE4

Topical Vitamin C for Treatment of Basal Cell Cancer

NCT04279535 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

NCT01611480 ·Status: COMPLETED ·Phase: PHASE2

Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia

NCT01861535 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects

NCT01567683 ·Status: COMPLETED ·Phase: PHASE1

1-Year Follow up to the 1473-IMIQ Study

NCT00114023 ·Status: COMPLETED

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

NCT00601016 ·Status: COMPLETED ·Phase: PHASE2

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

NCT02385188 ·Status: COMPLETED ·Phase: PHASE3

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

NCT06973473 ·Status: NOT_YET_RECRUITING

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

NCT03071679 ·Status: COMPLETED ·Phase: PHASE1

Study With a Topical Gel to Treat Common Warts in Adults

NCT00117871 ·Status: COMPLETED ·Phase: PHASE2

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study

NCT03901690 ·Status: UNKNOWN ·Phase: PHASE3